Go to Header
Go to Navigation
Go to Content
Go to Footer
Login
Help
中文（繁體）
Research Resources
CUHK UPDates
Theses
Experts List
User Guides
About Us
List of Researchers
> Professor Jun YU
Home
Research Outputs
Researcher Profiles
Department Profiles
Research Areas
Professor YU Jun
Personal Information
Position and Department
Professor
,
Department of Medicine and Therapeutics
ORCiD
0000-0001-5008-2153
CUHK Research Outputs
1 of 17
Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma
(
2024
)
Defining the biogeographical map and potential bacterial translocation of microbiome in human 'surface organs'
(
2024
)
Gut mycobiome in metabolic diseases: mechanisms and clinical implication
(
2024
)
High Soluble Fiber Promotes Colorectal Tumorigenesis Through Modulating Gut Microbiota and Metabolites in Mice
(
2024
)
Integrative analysis reveals associations between oral microbiota dysbiosis and host genetic and epigenetic aberrations in oral cavity squamous cell carcinoma
(
2024
)
Lactococcus lactis HkyuLL 10 suppresses colorectal tumourigenesis and restores gut microbiota through its generated alpha-mannosidase
(
2024
)
LOX-1 acts as an N6-methyladenosine-regulated receptor for Helicobacter pylori by binding to the bacterial catalase
(
2024
)
Mapping the pancancer metastasis tumor microbiome
(
2024
)
Peptostreptococcus anaerobius mediates anti-PD1 therapy resistance and exacerbates colorectal cancer via myeloid-derived suppressor cells in mice
(
2024
)
Spatial proteomics of immune microenvironment in nonalcoholic steatohepatitis-associated hepatocellular carcinoma
(
2024
)
Targeting squalene epoxidase restores anti-PD-1 efficacy in metabolic dysfunction-associated steatohepatitis-induced hepatocellular carcinoma
(
2024
)
VSTM2A reverses immunosuppression in colorectal cancer by antagonizing the PD-L1/PD-1 interaction
(
2024
)
632 Impact of Epidemiologic Evolution, Diet and Early Life Processed Food Intake On Microbiome Variance In Crohn's Disease. The International Enigma Study
(
2023
)
ALKBH5 Drives Immune Suppression via targeting AXIN2 to Promote Colorectal Cancer and is a Target for Boosting Immunotherapy
(
2023
)
Altered gut microbiome composition by appendectomy contributes to colorectal cancer
(
2023
)
Altered gut microbiota of obesity subjects promotes colorectal carcinogenesis in mice
(
2023
)
An Update of G-Protein-Coupled Receptor Signaling and Its Deregulation in Gastric Carcinogenesis
(
2023
)
A Probiotic Formula for Modulation of Colorectal Cancer Risk via Reducing CRC-Associated Bacteria
(
2023
)
Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma
(
2023
)
Bifidobacterium triple viable powder/capsule: How effective it is against gastrointestinal diseases?
(
2023
)
Cancer-associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2–IGF1R and Hippo–YAP1 signaling pathways
(
2023
)
Carnobacterium maltaromaticum boosts intestinal vitamin D production to suppress colorectal cancer in female mice
(
2023
)
Colorectal Cancer Subtyping With Microbiome—A Game Changer for Personalized Medicine?
(
2023
)
Combining methylated SEPTIN9 and RNF180 plasma markers for diagnosis and early detection of gastric cancer
(
2023
)
Decreased TMIGD1 aggravates colitis and intestinal barrier dysfunction via the BANF1-NF-κB pathway in Crohn's disease
(
2023
)
DOP48 Key Anti-Inflammatory Faecalibacterium prausnitzii is Heterogeneous and Diverse in the East and West and in Health and Crohn's disease. The ENIGMA study
(
2023
)
Effect of food additives on key bacterial taxa and the mucosa-associated microbiota in Crohn's disease. The ENIGMA study
(
2023
)
Excess body weight: Novel insights into its roles in obesity comorbidities
(
2023
)
Extrachromosomal circular DNA in colorectal cancer: biogenesis, function and potential as therapeutic target
(
2023
)
Faecalibacterium prausnitzii Abrogates Intestinal Toxicity and Promotes Tumor Immunity to Increase the Efficacy of Dual CTLA4 and PD-1 Checkpoint Blockade
(
2023
)
Gut microbes promote chemoradiotherapy resistance via metabolic cross-feeding
(
2023
)
Gut microbiome and metabolome: The crucial players in inflammatory bowel disease
(
2023
)
Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment
(
2023
)
Gut microbiota in colorectal cancer development and therapy
(
2023
)
Is this the end of colonoscopy screening for colorectal cancer? An Asia-Pacific perspective
(
2023
)
Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis
(
2023
)
Mechanistic insight of SARS-CoV-2 infection using human hepatobiliary organoids
(
2023
)
METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy
(
2023
)
Microbial metabolites in colorectal tumorigenesis and cancer therapy
(
2023
)
MLK4 promotes glucose metabolism in lung adenocarcinoma through CREB-mediated activation of phosphoenolpyruvate carboxykinase and is regulated by KLF5
(
2023
)
Mo1807 The Secretomes of Colonic Mucosa-Associated Microbiota in Crohn's Disease and Health Identify Key Bacteria Driving Pro- and Anti-Inflammatory Responses. The ENIGMA Study
(
2023
)
Mo1811 Characterization of The Key Anti-Inflammatory Bacterium Faecalibacterium Prausnitzii Internationally in Health and Crohn's Disease. The ENIGMA Study
(
2023
)
Mo1815 Characterization of The Colonic Mucosa-Associated Metagenome Reveals Novel Microbes and Geographically Distinct Communities in Health and Crohn's Disease. The ENIGMA Study
(
2023
)
P925 Deep functional assessment of the colonic mucosa-associated microbiota in Crohn's disease and health identifies pro- and anti- inflammatory secretomes and associated bacterial consortia. The ENIGMA study
(
2023
)
PacBio sequencing of human fecal samples uncovers the DNA methylation landscape of 22 673 gut phages
(
2023
)
Parabacteroides distasonis uses dietary inulin to suppress NASH via its metabolite pentadecanoic acid
(
2023
)
Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application
(
2023
)
Protocadherin 20 maintains intestinal barrier function to protect against Crohn's disease by targeting ATF6
(
2023
)
Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8+ T cells
(
2023
)
SEPT2 crotonylation promotes metastasis and recurrence in hepatocellular carcinoma and is associated with poor survival
(
2023
)
Most Relevant Area
Cancer Biology
(
Experimental biology
)
Related Area
Genetics and genomics
(
Experimental biology
)
Share Link
Last updated on 2024-03-09 at 16:08
Share Link
Your name*
Your email*
Recipient's name*
Recipient's email*
Message
Auxilliary Information
No information will be stored or shared with any third party.
Cancel
Our policy towards the use of cookies
All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Ok to Continue
Cookie Policy
